Guruprasad S.: Advancing Non-Invasive Hemoglobin Screening Through Independent Clinical Validation
Guruprasad S., Vice President and Global Director of Bosch Global Software Technologies, shared a post on LinkedIn:
“Publication Alert: Bosch Vivaray
Independent Clinical Evaluation Published in PLOS ONE
A significant milestone in advancing non-invasive hemoglobin screening through scientific evidence and clinical validation.
Proud to share the publication of an independent multicenter clinical evaluation of Bosch Vivaray Hb Pro in PLOS ONE, a reputed international peer-reviewed scientific journal.
Key highlights:
- Multicenter Clinical Evaluation: 763 participants across four clinical sites, evaluating Vivaray Hb Pro against laboratory reference measurements.
- Encouraging Clinical Performance: Mean absolute error (MAE) of approximately 1.5 g/dL overall, improving to 1.2 g/dL in the 8.1–13 g/dL hemoglobin range.
- Clinical Applicability: Supporting the potential of rapid, painless, non-invasive hemoglobin assessment for initial anemia screening across primary healthcare, community screening, and resource-constrained settings.
This publication builds on years of sustained innovation and scientific development, with earlier peer-reviewed research in:
- Journal of Medical and Biological Engineering – Springer Nature (2022)
- IEEE – A Novel Noninvasive Hemoglobin Sensing Device for Anemia Screening (2021)
- IEEE – Non-Invasive Estimation of Hemoglobin Using a Multi-Model Stacking Regressor
From fundamental engineering innovation to independent clinical evidence, this journey reflects the power of multidisciplinary collaboration, scientific rigor, and purpose-driven technology advancement for the benefit of Masses.
A proud moment for the entire Bosch Vivaray team and so many more who have contributed to advancing accessible healthcare innovation.”
Title 1: Vivaray Hb pro non-invasive hemoglobin device: A prospective diagnostic accuracy study measuring agreement with a calibrated blood cell counter
Authors: Devesh Kumar, Sunita Kapoor, Ambanna Gowda, Dipti Gupta, Harsh Mittal, Suneet Sood
Read the Full Article on PLOS ONE
Title 2: Non-invasive Estimation of Clinical Severity of Anemia Using Hierarchical Ensemble Classifiers
Authors: Sushovan Chakraborty, Krity Kansara, R Dinesh Kumar, Dhivya Swaminathan, Kiran Aatre, Soumyadipta Acharya
Read the Full Article on Journal of Medical and Biological Engineering
Title 3: A Novel Noninvasive Hemoglobin Sensing Device for Anemia Screening
Authors: R. Dinesh Kumar, S. Guruprasad, Krity Kansara, K. N. Raghavendra Rao, Murali Mohan, Manjunath Ramakrishna Reddy
Read the Full Article on IEEE Sensors Journal
Title 4: Non-Invasive Estimation of Hemoglobin Using a Multi-Model Stacking Regressor
Authors: Soumyadipta Acharya, Dhivya Swaminathan, Sreetama Das, Krity Kansara, Sushovan Chakraborty, Dinesh Kumar R
Read the Full Article on IEEE Journal of Biomedical and Health Informatics
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery